ALLcrimesfood&drugstaxestelecomcommercehealthconservationtransportationagricultureveteransbrowse all titles »
0

42 U.S.C. § 300cc–41Additional authorities

submitted 82 years ago by Pub. L. 100-607 to r/title-42-THE-PUBLIC-HEALTH-AND-WELFARE · 371 words · no verdicts yet

in plain englishAI-generated · not legal advice

The Director of the Office of AIDS Research gets broad powers to run AIDS research: expanding clinical trials for at-risk groups, funding specialized lab materials, and supporting research abroad. The Director can also acquire facilities and sign contracts as needed. The Director must build cooperation projects linking federal, state, local, and private health groups.

(a) In general: In doing AIDS research, the Director of the Office has these powers. (1) The Director must develop and expand clinical trials of AIDS treatments and therapies, including trials aimed at women, infants, children, people with hemophilia, and minorities. (2) The Director may help establish or support large-scale development, early screening, production, or distribution of specialized biological materials and other substances used in AIDS research, and may set safety standards for people who use them. (3) The Director may support (A) AIDS research done outside the U.S. by qualified foreign researchers, if it can reasonably be expected to benefit people in the U.S., (B) collaborative research involving both American and foreign participants, and (C) training American scientists abroad and foreign scientists here. (4) The Director may encourage and coordinate AIDS research done by private industry that shows a particular ability to do it well. (5) The Director may (A) acquire, improve, repair, operate, and maintain labs, other research facilities, equipment, and other property needed for this work, (B) give grants for building or renovating facilities, and (C) - without following the normal property rule in section 8141 of title 40 - lease or otherwise get buildings, or parts of buildings, in Washington D.C. or nearby communities for NIH's use, for up to ten years. (6) Subject to section 284(b)(2), and without following the normal contracting rules in section 3324 of title 31 and section 6101 of title 41, the Director may sign contracts and cooperative agreements with any public agency, or with any person, firm, association, corporation, or school, as needed to speed up and coordinate AIDS research. (b) Projects for cooperation among public and private health entities: While carrying out (a), the Director must set up projects that get federal agencies, state, local, and regional public health agencies, and private organizations working together on research into diagnosing, preventing, and treating AIDS.
the actual law source: uscode.house.gov ↗public domain
(a) In general

In carrying out AIDS research, the Director of the Office

(1)

shall develop and expand clinical trials of treatments and therapies for infection with the etiologic agent for acquired immune deficiency syndrome, including such clinical trials for women, infants, children, hemophiliacs, and minorities;

(2)

may establish or support the large-scale development and preclinical screening, production, or distribution of specialized biological materials and other therapeutic substances for AIDS research and set standards of safety and care for persons using such materials;

(3)

may support—

(A)

AIDS research conducted outside the United States by qualified foreign professionals if such research can reasonably be expected to benefit the people of the United States;

(B)

collaborative research involving American and foreign participants; and

(C)

the training of American scientists abroad and foreign scientists in the United States;

(4)

may encourage and coordinate AIDS research conducted by any industrial concern that evidences a particular capability for the conduct of such research;

(5)
(A)

may acquire, improve, repair, operate, and maintain laboratories, other research facilities, equipment, and such other real or personal property as the Director of the Office determines necessary;

(B)

may make grants for the construction or renovation of facilities; and

(C)

may acquire, without regard to section 8141 of title 40 by lease or otherwise through the Administrator of General Services, buildings or parts of buildings in the District of Columbia or communities located adjacent to the District of Columbia for the use of the National Institutes of Health for a period not to exceed ten years; and

(6)

subject to section 284(b)(2) of this title and without regard to section 3324 of title 31 and section 6101 of title 41, may enter into such contracts and cooperative agreements with any public agency, or with any person, firm, association, corporation, or educational institution, as may be necessary to expedite and coordinate research relating to acquired immune deficiency syndrome.

(b) Projects for cooperation among public and private health entities

In carrying out subsection (a), the Director of the Office shall establish projects to promote cooperation among Federal agencies, State, local, and regional public health agencies, and private entities, in research concerning the diagnosis, prevention, and treatment of acquired immune deficiency syndrome.

Source credit: (July 1, 1944, ch. 373, title XXIII, § 2354, formerly § 2351, as added Pub. L. 100–607, title II, § 201(4), Nov. 4, 1988, 102 Stat. 3076; renumbered § 2354 and amended Pub. L. 103–43, title XVIII, § 1801(a)(2), (b), June 10, 1993, 107 Stat. 192, 196; Pub. L. 109–482, title I, § 104(b)(2)(D), Jan. 15, 2007, 120 Stat. 3693.)

history & why it existsrecord from the source credit
  • 1944Enacted · Pub. L. 100-607 · 102 Stat. 3076
  • 1993Amended · Pub. L. 103-43 · 107 Stat. 192, 196
  • 2007Amended · Pub. L. 109-482 · 120 Stat. 3693

A history note hasn’t been published yet. The record shows enactment by Pub. L. 100-607 on 1944-07-01.

all 0 arguments · sorted by: best

0/280

no arguments yet — make the first case